Enggid, Felipe T.
HRN: 28-21-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/06/2025
12/13/2025
IV
4.5g
Q8h
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes